Introduction/Background The aim of the current study is to assess the prognostic value of the lymphocyte-monocyte ratio (LMR) in patients with uterine sarcoma.
Methodology We examined the LMR as a prognostic variable in a cohort of 66 patients with uterine sarcoma who underwent surgical resection. Patients were categorized into two groups based on the LMR using cut-off values determined by receiver operating characteristic curve (ROC) analysis. We assessed the effect of the LMR on progression-free survival (PFS) and validated the LMR as independent predictor of survival.
Results Using data from the whole cohort, the optimized LMR cut-off value selected using the ROC curve was 5.86 for PFS. The LMR-low and LMR-high groups included 45 (68.2%) and 21 (31.8%) patients, respectively. The 5-year PFS rates in the LMR-low and LMR-high groups were 69.0% and 94.4%, respectively (p=0.024). Via multivariate analysis, we identified FIGO, residual tumor after surgery, and LMR as the most valuable prognostic factors affecting PFS (p=0.039, p=0.018 and p=0.043, respectively).
Conclusion The LMR is an independent prognostic factor affecting the PFS of patients with uterine sarcoma.
Disclosure Nothing to disclose.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.